A typical business model consists of three components–value proposition, value-chain
structure and revenue generation. These components are used to give a general description …

Startup, a business aid published on www. evelexa. com. Evelexa is an online resource for
biotech entrepreneurs and investors, which he launched in 2001 and grew to a membership …

For more than a decade, there has been widespread & increasing concern that the ability of
the US to achieve sustained economic growth & long-term prosperity is adversely affected …

Industrial biotechnology is a key technology for future economic development. Governments
are increasingly aware of the impor-tance of industrial biotechnology, and many are …

In industries populated by entrepreneurial high technology firms, the rapid development of
new products is viewed as a key determinant of success. Developing a portfolio of new …

After thirty years the numbers are in on the biotech business—and it's not what we expected.
The industry in aggregate has lost money. R&D performance has not radically improved …

LEAD: Seven years after leaving the cushion of a corporate research post to catch what he
saw as the''wave of the future,''George Rathmann is beginning to feel confident that …

Biotechnology is close to becoming a $10 billion a year industry. Nature Biotechnologys
annual survey of company revenue and profits-this year encompassing data from the …

Reinventing the biotech manager | Nature Biotechnology Skip to main content Thank you for
visiting nature.com. You are using a browser version with limited support for CSS. To obtain the …

A survey of Canadian biotechnology firms investigated the impact of their context on their
strategies and performance. This paper reports two kinds of exploratory findings: a …